ArticleEuropean journal of medical research2023

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway.

Yanqing Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.